FUCHS HENRY J has filed 20 insider transactions across 1 company since April 2022.
Most recent transaction: a grant/award of 300 shares of BIOMARIN PHARMACEUTICAL INC ($BMRN) on April 30, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 300 | $68.65 | 197,172.0000 | 191,595,000 | 0.15% | 0.00% |
| Sept. 13, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | F | Common Stock | 12098 | $84.90 | 185,074.0000 | 191,595,000 | 6.14% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 18240 | $0.00 | 230,357.0000 | 191,595,000 | 8.60% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | F | Common Stock | 33485 | $83.87 | 196,872.0000 | 191,595,000 | 14.54% | 0.02% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Stock Option (Right to Buy Common Stock) | 40860 | $0.00 | 40,860.0000 | 191,595,000 | 9999.99% | 0.02% |
| March 5, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | S | Common Stock | 35341 | $85.18 | 212,117.0000 | 191,595,000 | 14.28% | 0.02% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 30640 | $0.00 | 224,894.0000 | 191,595,000 | 15.77% | 0.02% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 13326 | $0.00 | 238,220.0000 | 191,595,000 | 5.93% | 0.01% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 9238 | $0.00 | 247,458.0000 | 191,595,000 | 3.88% | 0.00% |
| April 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 317 | $66.88 | 176,504.0000 | 188,963,000 | 0.18% | 0.00% |
| Dec. 1, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 17750 | $0.00 | 194,254.0000 | 188,963,000 | 10.06% | 0.01% |
| Aug. 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | S | Common Stock | 12000 | $90.43 | 176,187.0000 | 188,963,000 | 6.38% | 0.01% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 16840 | $0.00 | 228,986.0000 | 188,963,000 | 7.94% | 0.01% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | F | Common Stock | 4799 | $87.74 | 224,187.0000 | 188,963,000 | 2.10% | 0.00% |
| March 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | F | Common Stock | 36000 | $93.41 | 188,187.0000 | 188,963,000 | 16.06% | 0.02% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Stock Option (Right to buy Common Stock) | 38450 | $0.00 | 38,450.0000 | 188,963,000 | 9999.99% | 0.02% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 36440 | $0.00 | 180,534.0000 | 188,963,000 | 25.29% | 0.02% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 18220 | $0.00 | 198,754.0000 | 188,963,000 | 10.09% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 13392 | $0.00 | 212,146.0000 | 188,963,000 | 6.74% | 0.01% |
| April 29, 2022 | BIOMARIN PHARMACEUTICAL INC | $BMRN | FUCHS HENRY J | President, Worldwide R&D | A | Common Stock | 341 | $62.41 | 144,094.0000 | 0 | 0.24% | 0.00% |